NCT07186296View on ClinicalTrials.gov

EXoPERT EMERALD Clinical Study

RecruitingOBSERVATIONAL
Enrollment

1,400

Participants

Timeline

Start Date

May 9, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Breast CancerColon CancerPancreatic CancerOvarian CancerLung Cancer
Interventions
DIAGNOSTIC_TEST

EXoPred

Performing invitro Diagnostics with devices developed by EXoPERT.

Trial Locations (2)

21218

ACTIVE_NOT_RECRUITING

John Hopkins University, Baltimore

40202

RECRUITING

KCTL, Louisville

All Listed Sponsors
collaborator

MCRA

INDUSTRY

lead

EXoPERT

INDUSTRY